BIOMAT Database Logo BIOMAT Database Logo

A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. 1987

N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette

UI MeSH Term Description Entries
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
July 1986, The New England journal of medicine,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.
August 1987, The American journal of pathology,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma.
November 1990, The Journal of experimental medicine,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients.
June 1993, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changes.
November 1992, International journal of dermatology,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Long-term follow up of lepromatous leprosy patients receiving intralesional recombinant gamma-interferon.
March 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
June 1992, The Journal of experimental medicine,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.
February 1988, Clinical and experimental immunology,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Rare transcripts of interferon-gamma detected in lepromatous leprosy cases.
March 1998, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
N M Samuel, and J M Grange, and S Samuel, and S Lucas, and O M Owilli, and S Adalla, and I M Leigh, and C Navarrette
Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy.
August 1986, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!